Press "Enter" to skip to content

Posts published in “Archives: Feed Items

UAB tests nasal vaccine for COVID-19

A new nasal vaccine tested at the University of Alabama at Birmingham is showing promising results. Some of the advantages: a nasal vaccine is easier to distribute and, when it comes to social distancing with patients, it may be safer for doctors and nurses. UAB scientists have been working with Maryland pharmaceutical company Altimmune, which has ties to the Alabama medical community. The endgame is to create an intranasal vaccine for COVID-19.

Possible safety issue spurs pause of COVID-19 antibody study

Independent monitors have paused enrollment in a study testing the COVID-19 antiviral drug remdesivir plus an experimental antibody therapy being developed by Eli Lilly that’s similar to a treatment President Donald Trump recently received.